BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinoma.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
09 12 2020
Historique:
received: 20 01 2020
accepted: 23 10 2020
entrez: 10 12 2020
pubmed: 11 12 2020
medline: 1 5 2021
Statut: epublish

Résumé

Cancer stem cells (CSCs) define a subpopulation of cancer cells that are resistant to therapy. However, little is known of how CSC characteristics are regulated. We previously showed that dormant cancer stem cells are enriched with a CD274

Identifiants

pubmed: 33299012
doi: 10.1038/s41598-020-78539-0
pii: 10.1038/s41598-020-78539-0
pmc: PMC7725823
doi:

Substances chimiques

BEX2 protein, human 0
CUL2 protein, human 0
Carrier Proteins 0
Cell Cycle Proteins 0
Cullin Proteins 0
FEM1B protein, human 0
Nerve Tissue Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

21592

Références

Oncotarget. 2015 Dec 29;6(42):44191-206
pubmed: 26496035
Dev Cell. 2007 Jul;13(1):127-39
pubmed: 17609115
EBioMedicine. 2017 Jun;20:27-38
pubmed: 28579242
Int J Cancer. 2010 Apr 1;126(7):1596-610
pubmed: 19711341
Biochim Biophys Acta. 2014 Apr;1843(4):675-84
pubmed: 24389246
Int J Biol Sci. 2017 Feb 12;13(3):286-294
pubmed: 28367093
Cancer Cell. 2012 Mar 20;21(3):283-96
pubmed: 22439924
Cell Stem Cell. 2013 Jan 3;12(1):49-61
pubmed: 23290136
Cell Stem Cell. 2018 Aug 02;23(2):289-305.e5
pubmed: 30017590
Mol Cancer. 2010 May 19;9:111
pubmed: 20482821
Nat Methods. 2017 Mar;14(3):251-258
pubmed: 28267743
Biochem Biophys Res Commun. 2013 Oct 25;440(3):431-6
pubmed: 24076122
Sci Rep. 2016 Jul 29;6:30707
pubmed: 27469492
Cancer Res. 2006 Jul 1;66(13):6665-74
pubmed: 16818640
J Mol Neurosci. 2013 May;50(1):78-87
pubmed: 22907646
Biochem Biophys Res Commun. 2012 Oct 26;427(3):574-80
pubmed: 23022184
PLoS One. 2013 Apr 23;8(4):e62002
pubmed: 23626764
Nat Rev Clin Oncol. 2018 Feb;15(2):95-111
pubmed: 28994423
Autophagy. 2013 Mar;9(3):432-3
pubmed: 23321557
Oncotarget. 2018 Apr 3;9(25):17282-17299
pubmed: 29707108
Cancer Sci. 2014 Jun;105(6):667-74
pubmed: 24673799
J Biol Chem. 2014 Oct 24;289(43):29892-911
pubmed: 25143383
Cell Mol Life Sci. 2016 May;73(10):2105-21
pubmed: 26781467
Nat Rev Cancer. 2008 Oct;8(10):755-68
pubmed: 18784658
EMBO Rep. 2013 Dec;14(12):1050-61
pubmed: 24232186
Sci Rep. 2015 Sep 16;5:14269
pubmed: 26373678
Oncotarget. 2017 Jul 25;8(30):50209-50220
pubmed: 28430586
Hum Mol Genet. 1999 Apr;8(4):611-9
pubmed: 10072429
Cell Cycle. 2017 Mar 19;16(6):556-564
pubmed: 28118078
Biochem Biophys Res Commun. 2007 Sep 7;360(4):721-7
pubmed: 17624298
Gene. 2011 Oct 10;485(2):153-9
pubmed: 21723927
FEBS Lett. 2004 Aug 27;573(1-3):83-92
pubmed: 15327980
Nucleic Acids Res. 2008 May;36(9):2939-47
pubmed: 18385154

Auteurs

Keiichi Tamai (K)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293, Japan. tamaikeiichi@med.tohoku.ac.jp.

Mao Nakamura-Shima (M)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Rie Shibuya-Takahashi (R)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293, Japan.

Shin-Ichiro Kanno (SI)

IDAC Fellow Research Group for DNA Repair and Dynamic Proteome Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, 980-8575, Japan.

Akira Yasui (A)

IDAC Fellow Research Group for DNA Repair and Dynamic Proteome Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, 980-8575, Japan.

Mai Mochizuki (M)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293, Japan.

Wataru Iwai (W)

Department of Gastroenterology, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Yuta Wakui (Y)

Department of Gastroenterology, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Makoto Abue (M)

Department of Gastroenterology, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Kuniharu Yamamoto (K)

Department of Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.
Division of Hepatobiliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyagino-ku, Sendai, Miyagi, Japan.

Koh Miura (K)

Department of Surgery, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Masamichi Mizuma (M)

Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan.

Michiaki Unno (M)

Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi, Japan.

Sadafumi Kawamura (S)

Department of Urology, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Ikuro Sato (I)

Department of Pathology, Miyagi Cancer Center, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Jun Yasuda (J)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Kazunori Yamaguchi (K)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Kazuo Sugamura (K)

Division of Molecular and Cellular Oncology, Miyagi Cancer Center Research Institute, 47-1, Medeshima-Shiode, Natori, Miyagi, Japan.

Kennichi Satoh (K)

Division of Cancer Stem Cell, Miyagi Cancer Center Research Institute, 47-1 Nodayama, Medeshima-Shiode, Natori, Miyagi, 981-1293, Japan.
Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyagino-ku, Sendai, Miyagi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH